deamino-arginine-vasopressin and Fetal-Growth-Retardation

This report is on six pregnancies of a woman with idiopathic diabetes insipidus detected after previous stillbirth, during the second pregnancy. On treatment with the only then available injectable substitute, an eutrophic child developed. Since the end of the second pregnancy, the patient has been treated with DDAVP. During the other five pregnancies dystrophic children were delivered due to placental insufficiencies. In the last pregnancy, after cessation of foetal growth a new growth phase could be initiated by improvement of placenta flow by haemodilution.

Topics: Adult; Cardiotocography; Cesarean Section; Deamino Arginine Vasopressin; Diabetes Insipidus; Dose-Response Relationship, Drug; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Ultrasonography, Prenatal